Objectives

1. Discuss how the microbiome in the human gut may interact with the immune system and alter response to malignancy
2. Describe recent results comparing microbiota and clinical outcomes of patients on trial at the University of Chicago
3. Discuss new research initiatives at the University of Chicago to better understand the microbiome and immunology